Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

563
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
563
Pancreatic Juice and Secretion01:26

Pancreatic Juice and Secretion

3.4K
Pancreatic juice is a clear fluid produced by the pancreas, containing water, salts, sodium bicarbonate, and enzymes vital for digestion in the small intestine. It helps break down large molecules, facilitating nutrient absorption.
When acidic chyme from the stomach enters the duodenum, it triggers the release of secretin, a hormone that prompts pancreatic juice secretion. After a fatty meal, cholecystokinin, another hormone, stimulates gallbladder contraction and enhances enzyme-rich...
3.4K
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

1.2K
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

DNA/RNA-Based Next-Generation Sequencing Improves the Early Diagnosis and Management of Neoplastic Bile Duct Strictures: A 6-Year, Prospective, Multi-Institutional, Real-Time Study.

Gastroenterology·2026
Same author

Impact of Retroactive Application of Updated Surveillance Guidelines on Endoscopy Center Capacity at a Large VA Health Care System.

Federal practitioner : for the health care professionals of the VA, DoD, and PHS·2026
Same author

PancreaSeq Genomic Classifier (PancreaSeq GC) Improves Pancreatic Cyst Classification and Detection of Advanced Neoplasia: A Multi-institutional Validation Study.

Annals of surgical oncology·2025
Same author

Carbon dots as probes in FLIM:a review of applications and advances in cellular imaging.

RSC advances·2025
Same author

Recurrent BEND2 Fusion Genes Identified by Whole Transcriptome Sequencing of Nonfunctional Pancreatic Neuroendocrine Tumors Correlate With Poor Patient Prognosis.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2025
Same author

Detection of Alternative Lengthening of Telomeres via Chromogenic In Situ Hybridization for the Prognostication of PanNETs and Other Neoplasms.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2024

Related Experiment Video

Updated: May 1, 2026

Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma
05:44

Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma

Published on: November 5, 2020

4.5K

Update on pancreatic cyst fluid analysis.

Matthew Rockacy1, Asif Khalid2

  • 1Division of Gastroenterology, Hepatology and Nutrition (Matthew Rockacy, Asif Khalid).

Annals of Gastroenterology
|April 10, 2014
PubMed
Summary
This summary is machine-generated.

Pancreatic cystic lesions (PCL) diagnosis is challenging due to their varied nature and malignant potential. Pancreatic cyst CEA levels are the most accurate marker for mucinous cysts, aiding in diagnosis.

Keywords:
EUSIPMNKRASPancreatic cysts

More Related Videos

Author Spotlight: Advancements in Retroperitoneal Approach for Necrotizing Pancreatitis
03:42

Author Spotlight: Advancements in Retroperitoneal Approach for Necrotizing Pancreatitis

Published on: March 15, 2024

1.6K
Treatment of Middle-segment Pancreatic Benign Tumor Using Laparoscopic Central Pancreatectomy with End-to-end Pancreatic Duct Reconstruction
05:11

Treatment of Middle-segment Pancreatic Benign Tumor Using Laparoscopic Central Pancreatectomy with End-to-end Pancreatic Duct Reconstruction

Published on: January 2, 2026

241

Related Experiment Videos

Last Updated: May 1, 2026

Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma
05:44

Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma

Published on: November 5, 2020

4.5K
Author Spotlight: Advancements in Retroperitoneal Approach for Necrotizing Pancreatitis
03:42

Author Spotlight: Advancements in Retroperitoneal Approach for Necrotizing Pancreatitis

Published on: March 15, 2024

1.6K
Treatment of Middle-segment Pancreatic Benign Tumor Using Laparoscopic Central Pancreatectomy with End-to-end Pancreatic Duct Reconstruction
05:11

Treatment of Middle-segment Pancreatic Benign Tumor Using Laparoscopic Central Pancreatectomy with End-to-end Pancreatic Duct Reconstruction

Published on: January 2, 2026

241

Area of Science:

  • Gastroenterology
  • Oncology
  • Pathology

Background:

  • Pancreatic cystic lesions (PCL) are frequently found incidentally, posing diagnostic challenges due to their diverse types and malignant potential.
  • Mucinous cysts, including intraductal papillary mucinous neoplasms (IPMN) and mucinous cystic neoplasms (MCN), represent a significant subset of PCL with malignant risk.
  • Current management is complicated by the difficulty in differentiating PCL and predicting their malignant transformation.

Approach:

  • Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) is a key diagnostic tool for PCL.
  • Analysis of cyst fluid includes tumor markers (e.g., CEA), cytology, mucins, DNA, and amylase.
  • Carcinogenic embryonic antigen (CEA) levels in pancreatic cyst fluid are the most reliable tumor marker for identifying mucinous cysts.

Key Points:

  • A CEA level cut-off of 192 ng/mL can identify approximately 75% of mucinous cysts, requiring 0.2–1.0 mL of cyst fluid.
  • KRAS mutations are highly specific but lack sensitivity for diagnosing mucinous cysts.
  • Cytology is valuable for detecting malignancy, particularly when a solid component is present within the cyst.

Conclusions:

  • Accurate diagnosis of PCL, especially mucinous subtypes, is crucial for appropriate management and risk stratification.
  • CEA levels represent a valuable biomarker in the diagnostic workup of pancreatic cystic lesions.
  • Ongoing research aims to identify novel markers to enhance diagnostic accuracy for PCL.